• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多发性内分泌腺瘤病]

[Multiple Endocrine Neoplasia].

作者信息

Uchino Shinya, Ito Akiko

机构信息

Dept. of Endocrine Surgery, Noguchi Thyroid Clinic and Hospital Foundation.

出版信息

Gan To Kagaku Ryoho. 2019 Jul;46(7):1114-1118.

PMID:31296813
Abstract

Multiple endocrine neoplasia(MEN)is an autosomal dominantly inherited tumor syndrome which develop tumors in multiple endocrine organs and its subtype, MEN1 and MEN2, are well known. The causative gene for MEN1 is the MEN1 gene located on chromosome 11q13. Primary hyperparathyroidism, pancreatic gastroduodenal neuroendocrine tumor, pituitary tumor, adrenal cortical hyperplasia, or thymic neuroendocrine tumor are the typical features of MEN1 patients. Pathogenic variant of the MEN1 gene is distributed in exons 2-10. The causative gene for MEN2 is the RET gene located on chromosome 10q11.2. MEN2 is characterized by medullary thyroid carcinoma, pheochromocytoma and primary hyperparathyroidism. MEN2 is divided into two clinical phenotypes, 2A and 2B. Pathogenic variant of the RET gene concentrated on exons 10, 11, 13-16 and there are strong association of the location of the pathogenic variant with disease phenotype. Recently, it is reported that the pathogenic variant of the CDKN1B gene located on chromosome 12p13 is the cause of MEN4. In this syndrome, MEN1- associated tumors of hyperparathyroidism, pituitary adenomas and neuroendocrine tumors of the pancreas or digestive tract with other endocrine tumors are found. The onset age is relatively high and it shows greater diversity of the tumors compared to MEN1.

摘要

多发性内分泌腺瘤病(MEN)是一种常染色体显性遗传肿瘤综合征,可在多个内分泌器官发生肿瘤,其亚型MEN1和MEN2广为人知。MEN1的致病基因是位于11q13染色体上的MEN1基因。原发性甲状旁腺功能亢进、胰腺胃十二指肠神经内分泌肿瘤、垂体瘤、肾上腺皮质增生或胸腺神经内分泌肿瘤是MEN1患者的典型特征。MEN1基因的致病变异分布在外显子2 - 10中。MEN2的致病基因是位于10q11.2染色体上的RET基因。MEN2的特征是甲状腺髓样癌、嗜铬细胞瘤和原发性甲状旁腺功能亢进。MEN2分为两种临床表型,即2A和2B。RET基因的致病变异集中在外显子10、11、13 - 16中,且致病变异的位置与疾病表型有很强的关联。最近有报道称,位于12p13染色体上的CDKN1B基因的致病变异是MEN4的病因。在这种综合征中,可发现与MEN1相关的甲状旁腺功能亢进肿瘤、垂体腺瘤以及胰腺或消化道的神经内分泌肿瘤和其他内分泌肿瘤。发病年龄相对较高,与MEN1相比,肿瘤表现出更大的多样性。

相似文献

1
[Multiple Endocrine Neoplasia].[多发性内分泌腺瘤病]
Gan To Kagaku Ryoho. 2019 Jul;46(7):1114-1118.
2
Multiple endocrine neoplasia, the old and the new: a mini review.多发性内分泌肿瘤,旧貌与新颜:一篇综述短文
G Chir. 2012 Nov-Dec;33(11-12):370-3.
3
[Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].[多发性内分泌腺瘤病I型(韦默斯综合征),临床表现形式,5例病例研究]
Vnitr Lek. 2016 Fall;62(9 Suppl 3):140-149.
4
Multiple Endocrine Neoplasias Type 44型多发性内分泌肿瘤
5
Updates on the genetics of multiple endocrine neoplasia.多种内分泌肿瘤遗传学研究进展。
Ann Endocrinol (Paris). 2024 Apr;85(2):127-135. doi: 10.1016/j.ando.2023.11.005. Epub 2024 Feb 5.
6
[Clinical characteristics of multiple endocrine neoplasia].[多发性内分泌腺瘤病的临床特征]
Bull Acad Natl Med. 2010 Jan;194(1):69-78; discussion 78-9.
7
Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.多发性内分泌腺瘤病(MEN)——综述及病例报告——散发性双侧嗜铬细胞瘤、甲状旁腺功能亢进和类马凡体型患者
Anticancer Res. 2000 Nov-Dec;20(6C):4877-87.
8
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).多发性内分泌腺瘤病 1 型(MEN1)和 4 型(MEN4)。
Mol Cell Endocrinol. 2014 Apr 5;386(1-2):2-15. doi: 10.1016/j.mce.2013.08.002. Epub 2013 Aug 8.
9
[MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022].[多发性内分泌肿瘤的MEN:何时引发MEN?2022年更新]
Rev Med Interne. 2023 Jan;44(1):12-18. doi: 10.1016/j.revmed.2022.10.002. Epub 2022 Oct 25.
10
A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.一个患有非典型2A型多发性内分泌肿瘤的葡萄牙家族中,RET基因第8外显子存在一个罕见的错义变异。
Hormones (Athens). 2016 Jul;15(3):435-440. doi: 10.14310/horm.2002.1691.